Pfizer Xalkori wins conditional marketing authorization in EU
Xalkori blocks signaling in a number of cell pathways supposed to be important for the growth and survival of tumor cells, by inhibiting the ALK fusion protein. With
Xalkori blocks signaling in a number of cell pathways supposed to be important for the growth and survival of tumor cells, by inhibiting the ALK fusion protein. With
Using Pincer platform, Mediomics will develop antigen-specific assays for antibody titer, affinity, glycosylation and aggregation and is also expected to culminate with beta-testing by Gallus Biopharmaceuticals. The company
According to the study data, the oral administration of laquinimod 0.5mg/day exhibitted the steady effect on remission and response rates in patients with moderate-to-severe CD versus placebo. Teva
The international study, which involved 775 patients with UC and 525 HCPs, in UC compared the views and beliefs of patients, physicians and specialist nurses. The survey, which
For the completion, the company has initiated the installation qualification (IQ) validation process through Biopharmax Group, which is handling the build-out of Pluristem’s facility. Following the successful IQ,
The new solution, BINOSTO (alendronate sodium), is intended for the treatment of osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. EffRx Pharmaceuticals chairman
The NDA included the data of clinical studies in more than 3,000 pregnant women at term including the EXPEDITE study. The 1,358 patient-based double blind, randomized, multicenter EXPEDITE
The drug is a oral soluble guanylate cyclase (sGC) stimulator which is designed to treat patients with either inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary hypertension (PH)
The solution is expected to support Tigermed’s expansion of operations into Europe and North America. Tigermed chairman and general manager Xiaoping Ye said Tigermed was seeking a CTMS
Oxtellar XR is an antiepileptic drug used as an adjunct therapy to treat partial seizures in adults and in children 6 to 17 years of age. Supernus chief